| Primary |
| Product Used For Unknown Indication |
56.5% |
| Drug Use For Unknown Indication |
19.6% |
| Blood Cholesterol Increased |
6.1% |
| High Density Lipoprotein Decreased |
4.4% |
| Blood Triglycerides Increased |
2.8% |
| Low Density Lipoprotein Increased |
2.2% |
| Hypertension |
1.8% |
| Hyperlipidaemia |
1.1% |
| Blood Cholesterol |
0.9% |
| Diabetes Mellitus |
0.7% |
| Blood Pressure |
0.5% |
| Prophylaxis |
0.5% |
| Dyslipidaemia |
0.5% |
| Cardiac Disorder |
0.4% |
| Blood Cholesterol Abnormal |
0.4% |
| Vitamin Supplementation |
0.4% |
| Hypercholesterolaemia |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Hypothyroidism |
0.2% |
| Coronary Artery Disease |
0.2% |
|
| Flushing |
38.6% |
| Pruritus |
15.7% |
| Paraesthesia |
7.7% |
| Skin Burning Sensation |
6.1% |
| Feeling Hot |
4.6% |
| Blood Glucose Increased |
3.5% |
| Rash |
2.5% |
| Headache |
2.4% |
| Erythema |
2.4% |
| Nausea |
2.2% |
| Hot Flush |
2.0% |
| Myalgia |
1.6% |
| Dizziness |
1.5% |
| Hyperhidrosis |
1.4% |
| Urticaria |
1.4% |
| Diarrhoea |
1.4% |
| Burning Sensation |
1.4% |
| Pruritus Generalised |
1.3% |
| Insomnia |
1.1% |
| Pain In Extremity |
1.1% |
|
| Secondary |
| Product Used For Unknown Indication |
49.5% |
| Drug Use For Unknown Indication |
17.4% |
| High Density Lipoprotein Decreased |
7.2% |
| Blood Cholesterol Increased |
6.2% |
| Blood Triglycerides Increased |
5.0% |
| Low Density Lipoprotein Increased |
4.5% |
| Hypertension |
2.3% |
| Blood Cholesterol |
1.1% |
| Diabetes Mellitus |
1.0% |
| Prophylaxis |
0.7% |
| Dyslipidaemia |
0.7% |
| Cardiac Disorder |
0.6% |
| Blood Cholesterol Abnormal |
0.6% |
| Hyperlipidaemia |
0.6% |
| Blood Pressure |
0.5% |
| Vitamin Supplementation |
0.5% |
| Blood Triglycerides |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Hypothyroidism |
0.4% |
| Arteriosclerosis |
0.3% |
|
| Flushing |
34.9% |
| Pruritus |
17.4% |
| Paraesthesia |
8.0% |
| Skin Burning Sensation |
6.7% |
| Feeling Hot |
4.3% |
| Rash |
3.6% |
| Blood Glucose Increased |
2.9% |
| Nausea |
2.4% |
| Erythema |
2.2% |
| Myalgia |
2.2% |
| Headache |
2.1% |
| Urticaria |
1.9% |
| Hot Flush |
1.8% |
| Pruritus Generalised |
1.5% |
| Hyperhidrosis |
1.4% |
| Diarrhoea |
1.4% |
| Wrong Technique In Drug Usage Process |
1.3% |
| Insomnia |
1.3% |
| Vomiting |
1.3% |
| Dizziness |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.5% |
| Drug Use For Unknown Indication |
18.6% |
| Hypertension |
8.6% |
| Blood Cholesterol Increased |
6.9% |
| Type 2 Diabetes Mellitus |
4.7% |
| Diabetes Mellitus |
4.0% |
| Pain |
3.3% |
| Cardiac Disorder |
2.8% |
| Depression |
2.5% |
| Atrial Fibrillation |
2.5% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Hyperlipidaemia |
2.1% |
| Blood Cholesterol |
1.8% |
| Rheumatoid Arthritis |
1.7% |
| Anxiety |
1.5% |
| Prophylaxis |
1.4% |
| Coronary Artery Disease |
1.3% |
| Osteoporosis |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Arthritis |
1.1% |
|
| Weight Decreased |
14.6% |
| Vomiting |
12.3% |
| Weight Increased |
11.2% |
| Drug Ineffective |
7.2% |
| Myocardial Infarction |
7.2% |
| Tremor |
4.2% |
| Pain |
4.1% |
| Nausea |
4.0% |
| Vision Blurred |
3.8% |
| Pain In Extremity |
3.3% |
| Pneumonia |
3.2% |
| Death |
3.0% |
| Dyspnoea |
2.9% |
| Rash |
2.9% |
| Renal Failure Acute |
2.9% |
| Somnolence |
2.9% |
| Diarrhoea |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Pancreatitis |
2.5% |
| Wheezing |
2.5% |
|
| Interacting |
| Diabetes Mellitus |
25.6% |
| Depression |
24.0% |
| Tachyarrhythmia |
12.3% |
| Blood Cholesterol Increased |
8.6% |
| Dyslipidaemia |
6.1% |
| High Density Lipoprotein Decreased |
6.1% |
| Drug Use For Unknown Indication |
3.3% |
| Hypertension |
3.3% |
| Blood Triglycerides Increased |
1.4% |
| Blood Cholesterol |
1.1% |
| Diabetes |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Anxiety |
0.8% |
| Cardiac Failure Congestive |
0.8% |
| Product Used For Unknown Indication |
0.8% |
| Anticoagulant Therapy |
0.6% |
| Arterial Occlusive Disease |
0.6% |
| Arterial Spasm |
0.6% |
| Low Density Lipoprotein Decreased |
0.6% |
|
| Myocardial Infarction |
51.2% |
| Flushing |
9.3% |
| Drug Interaction |
4.7% |
| Dysstasia |
4.7% |
| Loss Of Consciousness |
4.7% |
| Overdose |
4.7% |
| Unevaluable Event |
4.7% |
| Urticaria |
4.7% |
| Fatigue |
2.3% |
| Oedema Peripheral |
2.3% |
| Potentiating Drug Interaction |
2.3% |
| Vasculitis |
2.3% |
| Weight Increased |
2.3% |
|
